Together, these data demonstrate that a comprehensive, molecular understanding of the potential inhibitory/regulatory function of the TCPTP C-terminal tail may provide a powerful novel route for modulating TCPTP-specific signaling pathways and, in turn, new treatments for diseases like cancer and diabetes. Here, PTPN2 is linked to cancer.